|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hayflick L and Moorhead PS: The serial
cultivation of human diploid cell strains. Exp Cell Res.
25:585–621. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Collado M and Serrano M: Senescence in
tumours: Evidence from mice and humans. Nat Rev Cancer. 10:51–57.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Braig M, Lee S, Loddenkemper C, Rudolph C,
Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T and
Schmitt CA: Oncogene-induced senescence as an initial barrier in
lymphoma development. Nature. 436:660–665. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartkova J, Rezaei N, Liontos M,
Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E,
Niforou K, Zoumpourlis VC, et al: Oncogene-induced senescence is
part of the tumorigenesis barrier imposed by DNA damage
checkpoints. Nature. 444:633–637. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rufini A, Tucci P, Celardo I and Melino G:
Senescence and aging: The critical roles of p53. Oncogene.
32:5129–5143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Provinciali M, Cardelli M, Marchegiani F
and Pierpaoli E: Impact of cellular senescence in aging and cancer.
Curr Pharm Des. 19:1699–1709. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nardella C, Clohessy JG, Alimonti A and
Pandolfi PP: Pro-senescence therapy for cancer treatment. Nat Rev
Cancer. 11:503–511. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Acosta JC and Gil J: Senescence: A new
weapon for cancer therapy. Trends Cell Biol. 22:211–219. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kupchan SM, Court WA, Dailey RG Jr,
Gilmore CJ and Bryan RF: Triptolide and tripdiolide, novel
antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J
Am Chem Soc. 94:7194–7195. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun L, Li H, Huang X, Wang T, Zhang S,
Yang J, Huang S, Mei H, Jiang Z and Zhang L: Triptolide alters
barrier function in renal proximal tubular cells in rats. Toxicol
Lett. 223:96–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reno TA, Kim JY and Raz DJ: Triptolide
inhibits lung cancer cell migration, invasion, and metastasis. Ann
Thorac Surg. 100:1817–1824; discussion 1824–1815. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang XH, Wong BC, Lin MC, Zhu GH, Kung
HF, Jiang SH, Yang D and Lam SK: Functional p53 is required for
triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB
activation in gastric cancer cells. Oncogene. 20:8009–8018. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li C, Xing G, Maeda K, Wu C, Gong L,
Sugiyama Y, Qi X, Ren J and Wang G: The role of breast cancer
resistance protein (Bcrp/Abcg2) in triptolide-induced testis
toxicity. Toxicol Res. 4:1260–1268. 2015. View Article : Google Scholar
|
|
15
|
Yang S, Chen J, Guo Z, Xu XM, Wang L, Pei
XF, Yang J, Underhill CB and Zhang L: Triptolide inhibits the
growth and metastasis of solid tumors. Mol Cancer Ther. 2:65–72.
2003.PubMed/NCBI
|
|
16
|
Wang Z, Jin H, Xu R, Mei Q and Fan D:
Triptolide downregulates Rac1 and the JAK/STAT3 pathway and
inhibits colitis-related colon cancer progression. Exp Mol Med.
41:717–727. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Phillips PA, Dudeja V, McCarroll JA,
Borja-Cacho D, Dawra RK, Grizzle WE, Vickers SM and Saluja AK:
Triptolide induces pancreatic cancer cell death via inhibition of
heat shock protein 70. Cancer Res. 67:9407–9416. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Astle MV, Hannan KM, Ng PY, Lee RS, George
AJ, Hsu AK, Haupt Y, Hannan RD and Pearson RB: AKT induces
senescence in human cells via mTORC1 and p53 in the absence of DNA
damage: Implications for targeting mTOR during malignancy.
Oncogene. 31:1949–1962. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sin S, Kim SY and Kim SS: Chronic
treatment with ginsenoside Rg3 induces Akt-dependent senescence in
human glioma cells. Int J Oncol. 41:1669–1674. 2012.PubMed/NCBI
|
|
20
|
Reno TA, Tong SW, Wu J, Fidler JM, Nelson
R, Kim JY and Raz DJ: The triptolide derivative MRx102 inhibits Wnt
pathway activation and has potent anti-tumor effects in lung
cancer. BMC Cancer. 16:4392016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Collado M, Blasco MA and Serrano M:
Cellular senescence in cancer and aging. Cell. 130:223–233. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dimitrova V and Arcaro A: Targeting the
PI3K/AKT/mTOR signaling pathway in medulloblastoma. Curr Mol Med.
15:82–93. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park JH, Kim JJ and Bae YS: Involvement of
PI3K-AKT-mTOR pathway in protein kinase CKII inhibition-mediated
senescence in human colon cancer cells. Biochem Biophys Res Commun.
433:420–425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu Y, Li N, Xiang R and Sun P: Emerging
roles of the p38 MAPK and PI3K/AKT/mTOR pathways in
oncogene-induced senescence. Trends Biochem Sci. 39:268–276. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Binet R, Ythier D, Robles AI, Collado M,
Larrieu D, Fonti C, Brambilla E, Brambilla C, Serrano M, Harris CC,
et al: WNT16B is a new marker of cellular senescence that regulates
p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer
Res. 69:9183–9191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu R, Zhang ZQ, Wang B, Jiang HX, Cheng L
and Shen LM: Berberine-induced apoptotic and autophagic death of
HepG2 cells requires AMPK activation. Cancer Cell Int. 14:492014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang HH, Lipovsky AI, Dibble CC, Sahin M
and Manning BD: S6K1 regulates GSK3 under conditions of
mTOR-dependent feedback inhibition of Akt. Mol Cell. 24:185–197.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim NW, Piatyszek MA, Prowse KR, Harley
CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay
JW: Specific association of human telomerase activity with immortal
cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ponnala S, Chetty C, Veeravalli KK, Dinh
DH, Klopfenstein JD and Rao JS: MMP-9 silencing regulates hTERT
expression via β1 integrin-mediated FAK signaling and induces
senescence in glioma xenograft cells. Cell Signal. 23:2065–2075.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Noureini SK and Wink M: Antiproliferative
effect of the isoquinoline alkaloid papaverine in hepatocarcinoma
HepG-2 cells - inhibition of telomerase and induction of
senescence. Molecules. 19:11846–11859. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lai SR, Cunningham AP, Huynh VQ, Andrews
LG and Tollefsbol TO: Evidence of extra-telomeric effects of hTERT
and its regulation involving a feedback loop. Exp Cell Res.
313:322–330. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kanaya T, Kyo S, Hamada K, Takakura M,
Kitagawa Y, Harada H and Inoue M: Adenoviral expression of p53
represses telomerase activity through down-regulation of human
telomerase reverse transcriptase transcription. Clin Cancer Res.
6:1239–1247. 2000.PubMed/NCBI
|
|
33
|
Harada K, Kurisu K, Sadatomo T, Tahara H
and Tahara E, Ide T and Tahara E: Growth inhibition of human glioma
cells by transfection-induced P21 and its effects on telomerase
activity. J Neurooncol. 47:39–46. 2000. View Article : Google Scholar : PubMed/NCBI
|
